Brenton Scott
Principal investigator, leads PULMOTECT, INC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$7.0MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $7.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 31, 2017 | NIH | SBIR Phase II Expanding the Market and Success Rates for Myeloablative Cancer Treatments Using PUL-042, an Innate Immune Stimulant | $999K | PULMOTECT, INC |
| Apr 22, 2016 | NIH | SBIR Phase II Expanding the Market and Success Rates for Myeloablative Cancer Treatments Using PUL-042, an Innate Immune Stimulant | $999K | PULMOTECT, INC |
| Mar 1, 2016 | NIH | SBIR Phase II Preventing and treating RSV pneumonia in immunocompromised cancer patients | $999K | PULMOTECT, INC |
| May 1, 2015 | NIH | SBIR Phase II Expanding the Market and Success Rates for Myeloablative Cancer Treatments Using PUL an Innate Immune Stimulant | $3.0M | PULMOTECT, INC |
| Apr 30, 2015 | NIH | SBIR Phase II Expanding the Market and Success Rates for Myeloablative Cancer Treatments Using PUL-042, an Innate Immune Stimulant | $982K | PULMOTECT, INC |
Peer ranks
Federal funding#144
Awards as PI#417
Patents#273
Companies
- PULMOTECT, INCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.